Showing 851-860 of 3380 results for "".
Physician Spotlight: J. Matthew Knight, MD, FAAD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-j-matthew-knight-md-faad/20561/Dermatologists must act now to extinguish burnout or risk dire consequences.Physician Spotlight: Vishal Anil Patel, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-vishal-anil-patel-md/23899/Pearls for Managing Rosacea During Home Isolation
https://practicaldermatology.com/topics/acne-rosacea/pearls-for-managing-rosacea-during-home-isolation/23279/Encourage patients to keep up with skincare and prescription regimens and be prepared to offer in-office procedures when appropriate.New In My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-otc-2/23325/Physician Spotlight: Crystal Aguh, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-crystal-aguh-md/23234/Physician Spotlight: Gary Goldenberg, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-gary-goldenberg-md/20424/It's all hands on deck when building out a new dermatology practice.Go Inside the Issues
https://practicaldermatology.com/topics/practice-management/go-inside-the-issues/21108/The Expanding Role for PD-1 Inhibitors for NMSCs
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-expanding-role-for-pd-1-inhibitors-for-nmscs/19937/The pool of potential patients that could be treated with PD-1 inhibitors is growing. Todd Schlesinger, MD discusses how these drugs may be used to treat a greater number of patients with NMSCs and addresses side effects and their management.Journal Club: Treating Itch and Lessons from the IL-4 and IL-13 Blockade
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-treating-itch-and-lessons-from-the-il-4-and-il-13-blockade/27025/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, chats with dermatologist Matthew Zirwas, MD, about how evaluations of itch can lead to treatment for atopic dermatitis, and his Journal of Drugs in Dermatology article "Unexpected Clinical Lessons Learned From IL-4 and IL-13 Blockade."Altreno's Approval, Psoriasis Insights
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-altreno-s-approval-psoriasis-insights--nxhineya/18236/Ortho Dermatologics' Altreno lotion is now approved for the topical treatment of acne vulgaris in patients ages 9 and up. Altreno, containing tretinoin 0.05%, will be available during the fourth quarter of this year. The FDA has accepted Ortho Dermatologics' resubmitted New Drug Application for Duob